HBV and HCV Therapy

Author： Lampertico Pietro   Aghemo Alessio   Viganò Mauro   Colombo Massimo  

Publisher： MDPI

E-ISSN： 1999-4915|1|3|484-509

ISSN： 1999-4915

Source： Viruses, Vol.1, Iss.3, 2009-10, pp. : 484-509

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclophilin Inhibitors as a Novel HCV Therapy

By Tang Hengli  

Viruses, Vol. 2, Iss. 8, 2010-08 ,pp. : 1621-1634

MDPI

Access to resources Recommend Favorite

Interferon-λ in HCV Infection and Therapy

By Pagliaccetti Nicole E.   Robek * Michael D.  

Viruses, Vol. 2, Iss. 8, 2010-08 ,pp. : 1589-1602

MDPI

Access to resources Recommend Favorite

Progress and Prospects of Anti-HBV Gene Therapy Development

By Maepa Mohube B.   Roelofse Ilke   Ely Abdullah   Arbuthnot Patrick  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-07 ,pp. : 17589-17610

MDPI

Access to resources Recommend Favorite

Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report

By Schewe Knud   Noah Christian   Sirma Hüseyin   Schmiedel Stefan   van Lunzen Jan   Rockstroh Jürgen Kurt   Schildgen Oliver  

Viruses, Vol. 2, Iss. 8, 2010-07 ,pp. : 1564-1570

MDPI

Access to resources Recommend Favorite

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 518-525

John Wiley & Sons Inc

Access to resources Recommend Favorite